The Potential Benefits of HPV E6/E7 mRNA Test in Cervical Cancer Screening in China

This study aims to evaluate the clinical performance of the HPV E6/E7 mRNA test in cervical cancer screening in China. A hospital-based study was conducted with mRNA, DNA, and liquid-based cytology (LBC) as primary screening tests. Each woman with a positive result received colposcopy with lesion-ta...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Shao-Kai, Guo, Zhen, Wang, Peng, Kang, Le-Ni, Jia, Man-Man, Wu, Ze-Ni, Chen, Qiong, Cao, Xiao-Qin, Zhao, Dong-Mei, Guo, Pei-Pei, Sun, Xi-Bin, Zhang, Jian-Gong, Qiao, You-Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7567165/
https://www.ncbi.nlm.nih.gov/pubmed/33123463
http://dx.doi.org/10.3389/fonc.2020.533253

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7567165/
https://www.ncbi.nlm.nih.gov/pubmed/33123463
http://dx.doi.org/10.3389/fonc.2020.533253

Ejemplares similares